These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15632707)

  • 1. Early detection of pancreatic cancer.
    Gullo L
    Pancreas; 2005 Jan; 30(1):91. PubMed ID: 15632707
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy.
    Kobayashi A; Yamaguchi T; Ishihara T; Tadenuma H; Nakamura K; Saisho H
    Gut; 2005 Jul; 54(7):1047. PubMed ID: 15951559
    [No Abstract]   [Full Text] [Related]  

  • 3. Many roles of endoscopic ultrasound in the evaluation of pancreatic neoplasms: getting to know its strengths and limitations.
    Tang RS
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1069-70. PubMed ID: 23782116
    [No Abstract]   [Full Text] [Related]  

  • 4. Slow growth of small pancreatic carcinoma with a 20-04 follow-up.
    Shimada K; Onaya H; Esaki M; Sakamoto Y; Nara S; Kosuge T; Mizuguchi Y; Hiraoka N
    Pancreas; 2009 Apr; 38(3):346-9. PubMed ID: 19307934
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in US diagnosis of pancreatic cancer.
    Hirooka Y; Goto H; Ito A; Hashimoto S; Hirai T; Niwa K; Takeda K; Hayakawa T
    Hepatogastroenterology; 2001; 48(40):916-22. PubMed ID: 11490840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors.
    Rickes S; Mönkemüller K; Malfertheiner P
    JOP; 2006 Nov; 7(6):584-92. PubMed ID: 17095837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary-mucinous tumor of the pancreas: the clinical research continues.
    Pezzilli R
    JOP; 2004 Jan; 5(1):53-5. PubMed ID: 14730125
    [No Abstract]   [Full Text] [Related]  

  • 8. Endosonographic evaluation of intraductal papillary mucinous tumors of the pancreas.
    Soweid A; Azar C; Labban B
    JOP; 2004 Jul; 5(4):258-65. PubMed ID: 15254360
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Kadayifci and Brugge.
    Kitano M; Kamata K; Kudo M
    Endoscopy; 2014 Apr; 46(4):358. PubMed ID: 24671861
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.
    Mancosu P; Bettinardi V; Passoni P; Gusmini S; Cappio S; Gilardi MC; Cattaneo GM; Reni M; Del Maschio A; Di Muzio N; Fazio F
    Radiother Oncol; 2008 Jun; 87(3):339-42. PubMed ID: 18486253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced power Doppler sonography of ductal pancreatic adenocarcinomas: correlation with digital subtraction angiography findings.
    Chen CH; Yang CC; Yeh YH; Huang MH
    J Clin Ultrasound; 2004 May; 32(4):179-85. PubMed ID: 15101078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2003. A 75-year-old man with a cystic lesion of the pancreas.
    Warshaw AL; Brugge WR; Lewandrowski KB; Pitman MB
    N Engl J Med; 2003 Nov; 349(20):1954-61. PubMed ID: 14614171
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraductal papillary mucinous tumors of the pancreas.
    Prasad SR; Sahani D; Nasser S; Farrell J; Fernandez-Del Castillo C; Hahn PF; Mueller PR; Saini S
    Abdom Imaging; 2003; 28(3):357-65. PubMed ID: 12719906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging.
    Sofuni A; Iijima H; Moriyasu F; Nakayama D; Shimizu M; Nakamura K; Itokawa F; Itoi T
    J Gastroenterol; 2005 May; 40(5):518-25. PubMed ID: 15942718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case.
    Krishnasamy R; Agarwal S; Singh S; Puri S; Sakhuja P; Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):553-6. PubMed ID: 17897923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the pancreatic ductal adenocarcinoma disease focused panel.
    Abdom Radiol (NY); 2019 Dec; 44(12):4002-4003. PubMed ID: 31624896
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential diagnosis of pancreatic lesions using endoscopic ultrasound].
    Dietrich CF; Jenssen C; Allescher HD; Hocke M; Barreiros AP; Ignee A
    Z Gastroenterol; 2008 Jun; 46(6):601-17. PubMed ID: 18537088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.
    Lytras D; Connor S; Bosonnet L; Jayan R; Evans J; Hughes M; Garvey CJ; Ghaneh P; Sutton R; Vinjamuri S; Neoptolemos JP
    Dig Surg; 2005; 22(1-2):55-61; discussion 62. PubMed ID: 15838173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses.
    Cook N; Olive KP; Frese K; Tuveson DA
    Methods Enzymol; 2008; 439():73-85. PubMed ID: 18374157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis.
    Gangi S; Fletcher JG; Nathan MA; Christensen JA; Harmsen WS; Crownhart BS; Chari ST
    AJR Am J Roentgenol; 2004 Apr; 182(4):897-903. PubMed ID: 15039161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.